Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine

Ananyeva, 1997, Oxidized LDL mediates the release of fibroblast growth factor-1, Arterioscler. Thromb. Vasc. Biol., 17, 445, 10.1161/01.ATV.17.3.445 Auge, 1996, The sphingomyelin–ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation, J. Biol. Chem., 271, 19251, 10.1074/jbc.271.32.19251 Auge, 1998, Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein, J. Biol. Chem., 273, 12893, 10.1074/jbc.273.21.12893 Auge, 1999, Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase, J. Biol. Chem., 274, 21533, 10.1074/jbc.274.31.21533 Auge, 2000, Sphingomyelin metabolites in vascular cell signaling and atherogenesis, Prog. Lipid Res., 39, 207, 10.1016/S0163-7827(00)00007-2 Balagopalakrishna, 1997, Minimally modified low density lipoproteins induce aortic smooth muscle cell proliferation via the activation of mitogen activated protein kinase, Mol. Cell. Biochem., 170, 85, 10.1023/A:1006840927835 Bass, 1983, Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation, J. Immunol., 130, 1910, 10.4049/jimmunol.130.4.1910 Berliner, 1997, Oxidized lipids in atherogenesis: formation, destruction and action, Thromb. Haemost., 78, 195, 10.1055/s-0038-1657525 Bhunia, 1996, Lactosylceramide stimulates Ras-GTP loading, kinases (MEK, Raf), p44 mitogen-activated protein kinase, and c-fos expression in human aortic smooth muscle cells, J. Biol. Chem., 271, 10660, 10.1074/jbc.271.18.10660 Bhunia, 1997, Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells, J. Biol. Chem., 272, 15642, 10.1074/jbc.272.25.15642 Burdon, 1989, Cell proliferation and oxidative stress, Free Radic. Res. Commun., 7, 149, 10.3109/10715768909087937 Chai, 1996, Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells: evidence for release of FGF-2, J. Biol. Chem., 271, 17791, 10.1074/jbc.271.30.17791 Chai, 2000, Relationship of molecular structure to the mechanism of lysophospholipid-induced smooth muscle cell proliferation, Am. J. Physiol. Heart Circ. Physiol., 279, H1830, 10.1152/ajpheart.2000.279.4.H1830 Chatterjee, 1992, Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation, Mol. Cell. Biochem, 111, 143, 10.1007/BF00229586 Chatterjee, 1998, Sphingolipids in atherosclerosis and vascular biology, Arterioscler. Thromb. Vasc. Biol., 18, 1523, 10.1161/01.ATV.18.10.1523 Chatterjee, 1996, Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation, Glycobiology, 6, 303, 10.1093/glycob/6.3.303 Chatterjee, 1997, Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells, Glycobiology, 7, 703, 10.1093/glycob/7.5.703 Chisolm, 2000, Regulation of cell growth by oxidized LDL, Free Radic. Biol. Med., 28, 1697, 10.1016/S0891-5849(00)00227-6 Chisolm, 1996, Oxidized lipoproteins and atherosclerosis, 129 Chisolm, 2000, The oxidative modification hypothesis of atherogenesis: an overview, Free Radic. Biol. Med., 28, 1815, 10.1016/S0891-5849(00)00344-0 Colles, 2000, Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events, J. Lipid Res., 41, 1188, 10.1016/S0022-2275(20)33425-8 Faham, 1998, Diversity does make a difference: fibroblast growth factor–heparin interactions, Curr. Opin. Struct. Biol., 8, 578, 10.1016/S0959-440X(98)80147-4 Glass, 2001, Atherosclerosis. The road ahead, Cell, 104, 503, 10.1016/S0092-8674(01)00238-0 Gospodarowicz, 1980, Extracellular matrix and control of proliferation of vascular endothelial cells, J. Clin. Invest., 65, 1351, 10.1172/JCI109799 Heery, 1995, Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells, J. Clin. Invest., 96, 2322, 10.1172/JCI118288 Heinecke, 2001, Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis, Arterioscler. Thromb. Vasc. Biol., 21, 1261, 10.1161/hq0801.095084 Herbert, 1996, The mitogenic effect of H2O2 for vascular smooth muscle cells is mediated by an increase of the affinity of basic fibroblast growth factor for its receptor, FEBS Lett., 395, 43, 10.1016/0014-5793(96)00998-2 Hessler, 1979, LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture, Atherosclerosis, 32, 213, 10.1016/0021-9150(79)90166-7 Hessler, 1983, Lipoprotein oxidation and lipoprotein-induced cytotoxicity, Arteriosclerosis, 3, 215, 10.1161/01.ATV.3.3.215 Kranenburg, 2001, Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists, Oncogene, 20, 1540, 10.1038/sj.onc.1204187 Lafont, 1995, Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis, J. Clin. Invest., 95, 1018, 10.1172/JCI117746 Libby, 2000, Changing concepts of atherogenesis, J. Intern. Med., 247, 349, 10.1046/j.1365-2796.2000.00654.x Marathe, 2000, Bioactive phospholipid oxidation products, Free Radic. Biol. Med., 28, 1762, 10.1016/S0891-5849(00)00234-3 Mashima, 2001, Oxidants and antioxidants in atherosclerosis, Curr. Opin. Lipidol., 12, 411, 10.1097/00041433-200108000-00007 Morel, 1983, Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid, J. Lipid Res., 24, 1070, 10.1016/S0022-2275(20)37921-9 Murrell, 1990, Modulation of fibroblast proliferation by oxygen free radicals, Biochem. J., 265, 659, 10.1042/bj2650659 Navab, 2001, HDL and the inflammatory response induced by LDL-derived oxidized phospholipids, Arterioscler. Thromb. Vasc. Biol., 21, 481, 10.1161/01.ATV.21.4.481 Parthasarathy, 2001, Did the antioxidant trials fail to validate the oxidation hypothesis?, Curr. Atheroscler. Rep., 3, 392, 10.1007/s11883-001-0077-9 Rao, 1992, Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression, Circ. Res., 70, 593, 10.1161/01.RES.70.3.593 Romanic, 1998, Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size, Stroke, 29, 1020, 10.1161/01.STR.29.5.1020 Ruef, 1998, Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal, Circulation, 97, 1071, 10.1161/01.CIR.97.11.1071 Sakai, 2000, Macrophage proliferation in atherosclerosis, Curr. Opin. Lipidol., 11, 503, 10.1097/00041433-200010000-00008 Shirhatti, 1985, A simple and sensitive method for monitoring drug-induced cell injury in culture cells, Anal. Biochem., 147, 410, 10.1016/0003-2697(85)90290-8 Steinbrecher, 1984, Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, Proc. Natl. Acad. Sci. U. S. A., 81, 3883, 10.1073/pnas.81.12.3883 Stiko, 1996, Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis, Arterioscler. Thromb. Vasc. Biol., 16, 194, 10.1161/01.ATV.16.2.194 Stiko-Rahm, 1992, Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells, Arterioscler. Thromb., 12, 1099, 10.1161/01.ATV.12.9.1099 Vlodavsky, 1996, Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor, Cancer Metastasis Rev., 15, 177, 10.1007/BF00437470 Weiss, 1993, The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor, J. Biol. Chem., 268, 5724, 10.1016/S0021-9258(18)53378-0 Winkles, 1993, Elevated expression of basic fibroblast growth factor in an immortalized rabbit smooth muscle cell line, Am. J. Pathol., 143, 518 Witztum, 1998, Oxidized phospholipids and isoprostanes in atherosclerosis, Curr. Opin. Lipidol., 9, 441, 10.1097/00041433-199810000-00008 Witztum, 2001, The oxidative modification hypothesis of atherosclerosis: does it hold for humans?, Trends Cardiovasc. Med., 11, 93, 10.1016/S1050-1738(01)00111-6 Wroblewski, 1955, Lactic dehydrogenase activity in blood, Proc. Soc. Exp. Biol. Med., 90, 210, 10.3181/00379727-90-21985 Zettler, 2001, Growth-promoting effects of oxidized low density lipoprotein, Can J. Cardiol., 17, 73 Zwijsen, 1992, Induction of platelet-derived growth factor chain A gene expression in human smooth muscle cells by oxidized low density lipoproteins, Biochem. Biophys. Res. Commun., 186, 1410, 10.1016/S0006-291X(05)81563-3